Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Testicular Neoplasms 1Teratoma 1Sarcoma 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1HIV Infections 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Etoposide 8Cisplatin 6Bleomycin 6Filgrastim 4Peripheral Blood Stem Cell Transplantation 3Ifosfamide 3Carboplatin 3etoposide phosphate 2Thiotepa 2Specimen Handling 2Radiotherapy 2Mesna 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2sodium thiosulfate 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal amphotericin B 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Second-Look Surgery 1Restraint, Physical 1Respiratory Physiological Phenomena 1Reoperation 1Radiation 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Teratoma × Restraint, Physical × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡